Prevalence of depression, anxiety in China during the COVID-19 pandemic: an updated systematic review and meta-analysis

BackgroundMental health risks associated with the aftermath of the COVID-19 pandemic are often overlooked by the public. The aim of this study was to investigate the effects of the COVID-19 pandemic on depression and anxiety disorders in China.MethodsStudies were analyzed and extracted in accordance...

Full description

Bibliographic Details
Main Authors: Xiang Bin, Ke-Yi Qu, Yu-Hao Wang, Li Chen, Yan-Jie Xiong, Jin Fu Wen, Hua-Bo Wei, Tan Bing, Chun-Yan Dan, Jia-Quan Zhu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2023.1267764/full
_version_ 1797361636996022272
author Xiang Bin
Ke-Yi Qu
Yu-Hao Wang
Li Chen
Yan-Jie Xiong
Jin Fu Wen
Hua-Bo Wei
Tan Bing
Chun-Yan Dan
Jia-Quan Zhu
author_facet Xiang Bin
Ke-Yi Qu
Yu-Hao Wang
Li Chen
Yan-Jie Xiong
Jin Fu Wen
Hua-Bo Wei
Tan Bing
Chun-Yan Dan
Jia-Quan Zhu
author_sort Xiang Bin
collection DOAJ
description BackgroundMental health risks associated with the aftermath of the COVID-19 pandemic are often overlooked by the public. The aim of this study was to investigate the effects of the COVID-19 pandemic on depression and anxiety disorders in China.MethodsStudies were analyzed and extracted in accordance with the PRISMA 2020 flowchart. The studies were screened and extracted using electronic databases including PubMed, Web of Science, Embase, Cochrane Library, and ClinicalTrials.gov according to the predefined eligibility criteria. The Cochrane Review Manager software 5.3.1 was used for data analysis and the risk of bias assessment.ResultsAs of 2023, a total of 9,212,751 Chinese have been diagnosed with COVID-19 infection. A total of 913,036 participants in 44 studies were selected following the eligibility criteria, the statistical information of which was collected for meta-analysis. The pooled prevalence of depression and anxiety were 0.31 (95% CI: 0.28, 0.35; I2 = 100.0%, p < 0.001) and 0.29 (95% CI: 0.23, 0.36; I2 = 100.0%, p < 0.001), respectively. After performing a subgroup analysis, the prevalence of depression among women, healthcare workers, students, and adolescents was 0.31 (95% CI: 0.22, 0.41), 0.33 (95% CI: 0.26, 0.44), 0.32 (95% CI: 0.26, 0.39), and 0.37 (95% CI: 0.31, 0.44), respectively.ConclusionThe prevalence of depression and anxiety among the Chinese was overall high. Monitoring and surveillance of the mental health status of the population during crises such as sudden global pandemics are imperative.Systematic review registrationhttps://clinicaltrials.gov/, identifier [CRD42023402190].
first_indexed 2024-03-08T15:57:31Z
format Article
id doaj.art-5e5349fa90b8492b9ce27198e159cdb9
institution Directory Open Access Journal
issn 2296-2565
language English
last_indexed 2024-03-08T15:57:31Z
publishDate 2024-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj.art-5e5349fa90b8492b9ce27198e159cdb92024-01-08T16:37:28ZengFrontiers Media S.A.Frontiers in Public Health2296-25652024-01-011110.3389/fpubh.2023.12677641267764Prevalence of depression, anxiety in China during the COVID-19 pandemic: an updated systematic review and meta-analysisXiang Bin0Ke-Yi Qu1Yu-Hao Wang2Li Chen3Yan-Jie Xiong4Jin Fu Wen5Hua-Bo Wei6Tan Bing7Chun-Yan Dan8Jia-Quan Zhu9Department of Otolaryngology, Fengdu County People's Hospital, Chongqing, ChinaDepartment of Stomatology, Fengdu County People's Hospital, Chongqing, ChinaShandong Academy of Medical Sciences, Shandong First Medical University, Shandong, ChinaDepartment of Pharmacy, Fengdu County People's Hospital, Chongqing, ChinaDepartment of Pharmacy, Fengdu County People's Hospital, Chongqing, ChinaInstitute of Cardiovascular Endocrinology of Shandong First Medical University, Shandong Academy of Medical Sciences, Shandong, ChinaDepartment of Pharmacy, Fengdu County People's Hospital, Chongqing, ChinaDepartment of Pharmacy, Fengdu County People's Hospital, Chongqing, ChinaDepartment of Human Resources, Fengdu County People's Hospital, Chongqing, ChinaDepartment of Pharmacy, Fengdu County People's Hospital, Chongqing, ChinaBackgroundMental health risks associated with the aftermath of the COVID-19 pandemic are often overlooked by the public. The aim of this study was to investigate the effects of the COVID-19 pandemic on depression and anxiety disorders in China.MethodsStudies were analyzed and extracted in accordance with the PRISMA 2020 flowchart. The studies were screened and extracted using electronic databases including PubMed, Web of Science, Embase, Cochrane Library, and ClinicalTrials.gov according to the predefined eligibility criteria. The Cochrane Review Manager software 5.3.1 was used for data analysis and the risk of bias assessment.ResultsAs of 2023, a total of 9,212,751 Chinese have been diagnosed with COVID-19 infection. A total of 913,036 participants in 44 studies were selected following the eligibility criteria, the statistical information of which was collected for meta-analysis. The pooled prevalence of depression and anxiety were 0.31 (95% CI: 0.28, 0.35; I2 = 100.0%, p < 0.001) and 0.29 (95% CI: 0.23, 0.36; I2 = 100.0%, p < 0.001), respectively. After performing a subgroup analysis, the prevalence of depression among women, healthcare workers, students, and adolescents was 0.31 (95% CI: 0.22, 0.41), 0.33 (95% CI: 0.26, 0.44), 0.32 (95% CI: 0.26, 0.39), and 0.37 (95% CI: 0.31, 0.44), respectively.ConclusionThe prevalence of depression and anxiety among the Chinese was overall high. Monitoring and surveillance of the mental health status of the population during crises such as sudden global pandemics are imperative.Systematic review registrationhttps://clinicaltrials.gov/, identifier [CRD42023402190].https://www.frontiersin.org/articles/10.3389/fpubh.2023.1267764/fullCOVID-19depressionanxietyChinasystematic reviewmeta-analysis
spellingShingle Xiang Bin
Ke-Yi Qu
Yu-Hao Wang
Li Chen
Yan-Jie Xiong
Jin Fu Wen
Hua-Bo Wei
Tan Bing
Chun-Yan Dan
Jia-Quan Zhu
Prevalence of depression, anxiety in China during the COVID-19 pandemic: an updated systematic review and meta-analysis
Frontiers in Public Health
COVID-19
depression
anxiety
China
systematic review
meta-analysis
title Prevalence of depression, anxiety in China during the COVID-19 pandemic: an updated systematic review and meta-analysis
title_full Prevalence of depression, anxiety in China during the COVID-19 pandemic: an updated systematic review and meta-analysis
title_fullStr Prevalence of depression, anxiety in China during the COVID-19 pandemic: an updated systematic review and meta-analysis
title_full_unstemmed Prevalence of depression, anxiety in China during the COVID-19 pandemic: an updated systematic review and meta-analysis
title_short Prevalence of depression, anxiety in China during the COVID-19 pandemic: an updated systematic review and meta-analysis
title_sort prevalence of depression anxiety in china during the covid 19 pandemic an updated systematic review and meta analysis
topic COVID-19
depression
anxiety
China
systematic review
meta-analysis
url https://www.frontiersin.org/articles/10.3389/fpubh.2023.1267764/full
work_keys_str_mv AT xiangbin prevalenceofdepressionanxietyinchinaduringthecovid19pandemicanupdatedsystematicreviewandmetaanalysis
AT keyiqu prevalenceofdepressionanxietyinchinaduringthecovid19pandemicanupdatedsystematicreviewandmetaanalysis
AT yuhaowang prevalenceofdepressionanxietyinchinaduringthecovid19pandemicanupdatedsystematicreviewandmetaanalysis
AT lichen prevalenceofdepressionanxietyinchinaduringthecovid19pandemicanupdatedsystematicreviewandmetaanalysis
AT yanjiexiong prevalenceofdepressionanxietyinchinaduringthecovid19pandemicanupdatedsystematicreviewandmetaanalysis
AT jinfuwen prevalenceofdepressionanxietyinchinaduringthecovid19pandemicanupdatedsystematicreviewandmetaanalysis
AT huabowei prevalenceofdepressionanxietyinchinaduringthecovid19pandemicanupdatedsystematicreviewandmetaanalysis
AT tanbing prevalenceofdepressionanxietyinchinaduringthecovid19pandemicanupdatedsystematicreviewandmetaanalysis
AT chunyandan prevalenceofdepressionanxietyinchinaduringthecovid19pandemicanupdatedsystematicreviewandmetaanalysis
AT jiaquanzhu prevalenceofdepressionanxietyinchinaduringthecovid19pandemicanupdatedsystematicreviewandmetaanalysis